ArticleDrugs - real world outcomes2020

Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer.

David M Waterhouse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.